# Oxybutynin for Post-surgical Bladder Pain and Urgency

> **NCT03952299** · PHASE3 · RECRUITING · sponsor: **University of California, Davis** · enrollment: 100 (estimated)

## Conditions studied

- Overactive Bladder Syndrome
- Neuropathic Bladder

## Interventions

- **DRUG:** Oxybutynin Transdermal Patch
- **DRUG:** Oral Oxybutynin

## Key facts

- **NCT ID:** NCT03952299
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03952299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03952299, "Oxybutynin for Post-surgical Bladder Pain and Urgency". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03952299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*